Swedish blood donor study reveals high prevalence of undiagnosed TBE infections

The number of infections by the tick-borne TBE virus that are not detected by health services is far higher than previously assumed.

Paxlovid May Not Be Associated With Lower Long COVID Risk, Survey Suggests

Nirmatrelvir-ritonavir (Paxlovid) did not reduce the odds of developing long COVID in vaccinated, non-hospitalized adults, survey data showed. About 16% of those treated with nirmatrelvir-ritonavir

January 6, 2024

ChatGPT Misdiagnosed Most Pediatric Cases

A large language model (LLM)-based chatbot gave the wrong diagnosis for the majority of pediatric cases, researchers found. ChatGPT version 3.5 reached an incorrect diagnosis

January 3, 2024

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, today announced it has been

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.